Bone diseases constitute a major issue for modern societies as a consequence of
progressive aging. Advantages such as open mesoporous channel, high specific surface …

Nanomedicines with controlled drug release have received increasing attention as an
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …

Mesoporous silica nanoparticles (MSNs) have been widely investigated as a nanocarrier for
the delivery of various cargoes in nanomedicine. The application of MSNs in tissue …

Porous inorganic materials such as mesoporous silica nanoparticles (MSNs), mesoporous
bioactive glasses (MBGs), porous calcium phosphates, and metal-organic frameworks …

Bone defect is a common problem and inducing osteoblasts differentiation is the key
process for the regenerative repair. Recently, the mesoporous silica (MS) coated …

Despite advancements in breast cancer treatment, bone metastases remain a significant
concern for patients with advanced breast cancer. Current theranostics strategies face …

In recent years, the unprecedented advances of biomedical nanotechnology have spurred
the development of drug delivery systems (DDSs) based on multifarious nanomaterials in …

Bone tissues are the main metastatic sites of many cancers, and bone metastasis is an
important cause of death. When bone metastasis occurs, dynamic interactions between …

Hierarchically nanostructured mesoporous carbonated hydroxyapatite microspheres have a
great potential for bone-implantable drug-delivery applications due to their large specific …

A mesoporous silica-based drug delivery device potentially useful for bone-specific drug
delivery has been designed, developed and characterized starting from MSU-type …